| Financial Year |
March 31 2023 |
| Monetary Funds |
1,508,197,897.58 |
| Held-for-trading Financial Assets |
854,413,039.75 |
| Notes Receivable |
2,002,193.50 |
| Accounts Receivable |
97,461,076.55 |
| Advances to Suppliers |
10,305,318.61 |
| Other Receivables |
13,407,639.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
454,069,132.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,862,547.81 |
| Total Current Assets |
2,951,837,551.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
27,931,398.12 |
| Under-construction Projects |
86,871,696.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,646,256.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,131,298.15 |
| Other Non-Current Assets |
11,125,460.46 |
| Sub-Total of Non-Current Assets |
152,743,443.79 |
| Total Assets |
3,104,580,994.94 |
| Short-Term Loans |
288,202,333.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
64,245,774.48 |
| Accounts Payable |
125,325,359.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,697,782.12 |
| Taxes Payable |
14,970,158.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
88,294.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
531,678.30 |
| Other Current Liabilities |
2,489,915.25 |
| Sub-Total of Current Liabilities |
867,222,028.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,679,451.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,056,094.19 |
| Total Liabilities |
870,278,122.99 |
| Paid-In Capital(Or Share Stock) |
132,000,000.00 |
| Capital Surplus |
1,384,993,425.84 |
| Surplus Reserve |
67,405,339.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
645,882,553.36 |
| Minority Stockholder's Interest |
4,021,553.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,230,281,318.60 |
| Owner's Equity（Stockholder's Equity） |
2,234,302,871.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,104,580,994.94 |
